Clinical Pharmacology and the Autonomic Nervous System

Ahlquist R. P. (1948). Study of the adrenotropic receptors. American Journal of Physiology, 153, 586.

Appenzeller O. (1970). The Autonomic Nervous System. London: North Holland Publishing.

Armstrong B. Stevens N. Doll R. (1974). Retrospective study of the association of rauwolfia derivatives and breast cancer in English women. Lancet, 2, 672.

British Medical Journal (1978). Editorial. Which drug for hypertension? British Medical Journal, 2, 75.

Bühler F. R. Laragh J. H. Vaughan E. D. Jnr. Brunner H. R. Gavras H. Baer L. (1973). Antihypertensive action of propranolol: Specific antirenin response in high and normal renin forms of essential renal, renovascular and malignant hypertension. American Journal of Cardiology, 32, 511.

Bühler F. R. Bertel O. Lütold B. E. (1978). Simplified and age-stratified antihypertensive therapy based on beta blockers. Cardiovascular Medicine, 2, 135.

de Champlain J. Farley L. Cousineau D. van Ameringen M. R. (1976). Circulating catecholamine levels in human and experimental hypertension. Circulation Research, 38, 109.

Cocco G. Burkart F. Chu D. Follath F. (1978). Intrinsic sympathomimetic activity of β-adrenoceptor blocking agents. European Journal of Clinical Pharmacology, 13, 1.

Cuthbert M. F. Collins R. F. (1975). Plasma levels and β-adrenoceptor blockade with acebutolol, practolol and propranolol in man. British Journal of Clinical Pharmacology, 2, 49.

Daggett P. Verner I. Carruthers M. (1978). Intraoperative management of phaeochromocytoma with sodium nitroprusside. British Medical Journal, 2, 311.

Davidson M. McD. Corall R. J. M. Shaw T. R. D. French E. B. (1976). Observations in man of hypoglycaemia during selective and non-selective beta-blockade. Scottish Medical Journal, 22, 69.

Davies B. Bannister R. Sever P. (1978). Pressure amines and monoamine-oxidase inhibitors for treatment of postural hypotension in autonomic failure. Lancet, 1, 172.

Deacon S. P. Karunayaka A. Barnett D. (1977). Acebutolol, atenolol and propranolol and metabolic responses to acute hypoglycaemia in diabetes. British Medical Journal 2, 1255.

Esler M. Julius S. Sweifler A. Randall O. Harburg E. Gardiner H. de Quattro V. (1977). Mild high-renin essential hypertension. Neurogenic human hypertension? New England Journal of Medicine, 292, 405.

Fox K. M. Chopra M. P. Portal R. W. Aber C. P. (1975). Long-term beta-blockade: Possible protection from myocardial infarction. British Medical Journal, 1, 117.

Fozard J. R. (1975). The animal pharmacology of drugs used in the treatment of migraine. Journal of Pharmacy and Pharmacology, 27, 297.

Frick M. H. Porsti P. (1976). Combined alpha-and beta-adrenoceptor blockade with labetalol in hypertension. British Medical Journal, 1, 1046.

Ghose K. Coppen A. Carroll D. (1977). Intravenous tyramine response in migraine before and during treatment with indoramin. British Medical Journal, 1, 1197.

Granville-Grossman K. L. Turner P. (1966). The effect of propranolol in anxiety. Lancet, 1, 788.

Hannington E. (1967). Preliminary report on tyramine headache. British Medical Journal, 1, 550.

Ikram H. (1977). Haemodynamic effects of beta-adrenergic blockade in hyperthyroid patients with and without heart failure. British Medical Journal, 1, 1505.

Johnson R. H. Spalding J. M. K. (1974) Disorders of the Autonomic Nervous System. Oxford: Blackwell.

Kersting F. Reid J. L. Dollery C. T. (1978). Site of action of methyldopa in lowering the blood pressure in man. Clinical and Experimental Pharmacology and Physiology, Supplement 4, 11.

Kobinger W. (1975). Central cardiovascular actions of clonidine. In Central Action of Drugs in Blood Pressure Regulation. Edited by Davies D. S. Reid J. L. London: Pitman Medical.

Kochar M. S. Itskovitz H. D. (1978). Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin. Lancet, 1, 1011.

Lake C. R. Ziegler M. G. Coleman M. D. Kopin I. J. (1977). Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. New England Journal of Medicine, 296, 208.

Lance J. W. (1973). Mechanism and Management of Headache, 2nd edition. London: Butterworths.

Levitt B. Cagin N. Kleid J. Somberg J. Gillis R. (1976). Role of nervous system in the genesis of cardiac rhythm disorders. American Journal of Cardiology, 37, 1111.

McDevitt D. G. (1977). The assessment of β-adrenoceptor blocking drugs in man. British Journal of Clinical Pharmacology, 4, 413.

McGrath M. A. Shepherd J. T. (1978). Histamine and 5-hydroxytryptamine-inhibition of transmitter release mediated by H₂-and 5-hydroxytryptamine receptors. Federation Proceedings, 37, 195.

Malik K. U. (1978). Prostaglandin-mediated inhibition of the vasoconstrictor responses of the isolated perfused rat splenic vasculature to adrenergic stimuli. Circulation Research, 43, 225.

Multicentre International Study (1975). Improvement in prognosis of myocardial infarction by long-term beta adrenoceptor blockade using practolol. British Medical Journal, 3, 735.

Nanda R. N. Johnson R. H. Keogh H. J. (1976). Treatment of neurogenic orthostatic hypotension with a monoamine oxidase inhibitor and tyramine. Lancet, 2, 1164.

Perkins C. M. Lee M. R. (1978). Flurbiprofen and fludrocortisone in severe autonomic neuropathy. Lancet, 2, 1058.

Philipp T. Disther A. Cordes U. (1978). Sympathetic nervous system and blood-pressure control in essential hypertension. Lancet, 2, 959.

Prichard B. N. C. (1974). β-adrenergic blocking drugs in angina pectoris. Drugs, 7, 55.

Rand J. J. Law M. Story D. F. Mc Culloch M. W. (1976). Effects of β-adrenoceptor blocking drugs on adrenergic transmission. Drugs, 11 (Supplement 1), 134.

Richards D. A. (1974). The effects of oral AH 5158, a combined α and β-adrenocep or antagonist, in healthy volunteers. British Journal of Clinical Pharmacology, 1, 505.

Sandler M. (1972). Migraine: A pulmonary disease? Lancet, 1, 618.

Shanks R. G. Hadden D. R. Lowe D. C. McDevitt D. C. Montgomery D. A. D. (1969). Controlled trial of propranolol in thyrotoxicosis. Lancet, 1, 993.

Singh B. N. Jewitt D. E. (1974). β-adrenergic receptor blocking drugs in cardiac arrhythmias. Drugs, 7, 426.

Sowton E. (1968). Beta-adrenergic blockade in cardiac infarction. Progress in Cardiovascular Diseases, 10, 561.

Stewart I. McD. G. (1976). Compared incidence of first myocardial infarction in hypertensive subjects under treatment containing propranolol or excluding β-recsptor blockade. Clinical Science and Molecular Medicine, 51 (Supplement 3), 509.

Stokes G. S. Oates H. F. (1978). Prazosin: New alpha-adrenergic blocking agent in treatment of hypertension. Cardiovascular Medicine, 3, 41.

Taggart P. Carruthers M. Somerville W. (1973). Electrocardiogram, plasma catecholamines and lipids, and their modification by oxprenolol when speaking before an audience. Lancet, 2, 341.

Thorner M. O. (1975). Dopamine is an important neurotransmitter in the autonomic nervous system. Lancet, 1, 662.

Tyrer P. Lader M. (1974). Response to propranolol and diazepam in somatic and psychic anxiety. British Medical Journal, 2, 14.

Wainscott G. Volans G. N. Wilkinson M. Faux G. A. (1975). Indoramin in prevention of migraine. Lancet, 2 32.

Waldenström A. P. Hjalmarson A. C. Thornell L. (1978). A possible role of noradrenaline in the development of myocardial infarction. American Heart Journal, 95, 43.

Wennmalm A. (1978). Influence of indomethacin on the systemic and pulmonary vascular resistance in man. Clinical Science and Molecular Medicine, 54, 141.

Wideroe T. E. Vigander T. (1974). Propranolol in migraine. British Medical Journal, 2, 699. Oxford University Press